Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
8,569,919
-
Share change
-
+504,909
-
Total reported value
-
$42,519,000
-
Price per share
-
$4.97
-
Number of holders
-
16
-
Value change
-
+$2,461,309
-
Number of buys
-
6
-
Number of sells
-
7
Institutional Holders of ENTASIS THERAPEUTICS HLDGS I - COM (ETTX) as of Q4 2019
As of 31 Dec 2019,
ENTASIS THERAPEUTICS HLDGS I - COM (ETTX) was held by
16 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
8,569,919 shares.
The largest 10 holders included
Novo Holdings A/S, Blackstone Group Inc, FRAZIER MANAGEMENT LLC, Sofinnova Investments, Inc., TPG Group Holdings (SBS) Advisors, Inc., EVENTIDE ASSET MANAGEMENT, LLC, GRANAHAN INVESTMENT MANAGEMENT INC/MA, VANGUARD GROUP INC, Janney Montgomery Scott LLC, and RENAISSANCE TECHNOLOGIES LLC.
This page lists
16
institutional shareholders reporting positions in this security
for the Q4 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.